Corbus Describes Phase 1 Results of ADC Trial for Bladder and Cervical Cancers
free of law Corbus Pharmaceuticals (NASDAQ:CRBP) said its antibody-drug conjugate, CRB-701, demonstrated promising efficacy and safety data in a Phase ...
Tag: Corbus
Recommended.
